Manjunath M Shenoy, Abhishek De, Bela Shah, Anupam Das, Abir Saraswat, Koushik Lahiri, Sheetal Yadav, Aarti Sarda, Disha Chakraborty, Dharmender J, Shruti Kamat, Yashika Doshi, Nelry Gonsalves, Ankita Choudhary, Dhiraj Dhoot, Namrata Mahadkar, Sumit Bhushan, Rujuta Gadkari, Hanmant Barkate
INTRODUCTION: Itraconazole follows non-linear pharmacokinetics and hence is recommended once daily, but in real-world practice, is commonly prescribed as twice daily. Hence, this study aimed to evaluate the efficacy and safety of super-bioavailable-itraconazole-130 mg (SB-130) and conventional-itraconazole-200 mg (CITZ-200) once daily compared with conventional-itraconazole-100 mg (CITZ-100) twice daily in glabrous tinea. METHODS: A total of 261 eligible patients were enrolled in this prospective, randomized, clinical study from December-2021 to August-2022 at seven centers in India...
2023: Drug Design, Development and Therapy